Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (11789)	11/6/2018 1:31:08 PM
From: scaram(o)uche	Respond to of 12215

Gives me a great idea for a company. Which does me no good whatsoever. Thanks!!

To: nigel bates who wrote (11789)	11/8/2018 2:09:23 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 12215

My great idea for a company.... next time you're in Cambridge, drop into Greg Winter's lab and ask him how long he keeps data/communications. We'll give you a wad of stock options. ;-) (I was the first to automate screening for anti-endotoxin MAbs, a collaboration with the instruments division of Cetus. Got hundreds of unique reagents and tools for preclinical testing. Very useful for human MAb screening, back in infancy days (we were using EBV transformants). But only ONE antibody caught my fancy. Sent data to Dr. Winter, and was invited over to discuss the project while carrying frozen cells. Westerns were also new science, but ours were a lock..... antibody was unlike anything, anywhere. Still is.)